HEADER SIGNALING PROTEIN 26-NOV-11 4A9I TITLE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1,2,3,4- TITLE 2 TETRAHYDROQUINAZOLIN-2-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN CONTAINING 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: N-TERMINAL BROMODOMAIN (BD1), RESIDUES 67-200; COMPND 5 SYNONYM: HUMAN BRD2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, HISTONE, EPIGENETIC READER, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.W.CHUNG,P.BAMBOROUGH REVDAT 3 08-MAY-19 4A9I 1 REMARK REVDAT 2 08-FEB-12 4A9I 1 JRNL REMARK MASTER REVDAT 1 11-JAN-12 4A9I 0 JRNL AUTH C.W.CHUNG,A.W.DEAN,J.M.WOOLVEN,P.BAMBOROUGH JRNL TITL FRAGMENT-BASED DISCOVERY OF BROMODOMAIN INHIBITORS PART 1: JRNL TITL 2 INHIBITOR BINDING MODES AND IMPLICATIONS FOR LEAD DISCOVERY. JRNL REF J.MED.CHEM. V. 55 576 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22136404 JRNL DOI 10.1021/JM201320W REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 68.04 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 18884 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.200 REMARK 3 FREE R VALUE TEST SET COUNT : 826 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1265 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.15 REMARK 3 BIN R VALUE (WORKING SET) : 0.3140 REMARK 3 BIN FREE R VALUE SET COUNT : 71 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2766 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 73 REMARK 3 SOLVENT ATOMS : 233 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.56000 REMARK 3 B22 (A**2) : -4.44000 REMARK 3 B33 (A**2) : -1.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.44000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.313 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.236 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.191 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.921 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2964 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4020 ; 1.077 ; 1.948 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 339 ; 4.517 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 137 ;39.121 ;24.818 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 530 ;14.559 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;24.828 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 416 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2248 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1706 ; 1.034 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2782 ; 2.040 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1258 ; 2.290 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1238 ; 3.596 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4A9I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-NOV-11. REMARK 100 THE DEPOSITION ID IS D_1290050482. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19710 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.0, 28% PEG 3350, 0.2 REMARK 280 M (NH4)2SO4, 20 DEGREES CELSIUS, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.11600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.76550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.11600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.76550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -5.74711 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 67.73161 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 47 REMARK 465 SER A 48 REMARK 465 SER A 49 REMARK 465 HIS A 50 REMARK 465 HIS A 51 REMARK 465 HIS A 52 REMARK 465 HIS A 53 REMARK 465 HIS A 54 REMARK 465 HIS A 55 REMARK 465 SER A 56 REMARK 465 SER A 57 REMARK 465 GLY A 58 REMARK 465 LEU A 59 REMARK 465 VAL A 60 REMARK 465 PRO A 61 REMARK 465 ARG A 62 REMARK 465 GLY A 63 REMARK 465 SER A 64 REMARK 465 HIS A 65 REMARK 465 MET A 66 REMARK 465 SER A 67 REMARK 465 ASN A 68 REMARK 465 PRO A 69 REMARK 465 LYS A 70 REMARK 465 LYS A 71 REMARK 465 PRO A 72 REMARK 465 GLY A 73 REMARK 465 ARG A 74 REMARK 465 GLN A 185 REMARK 465 GLU A 186 REMARK 465 LEU A 187 REMARK 465 VAL A 188 REMARK 465 VAL A 189 REMARK 465 THR A 190 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 193 REMARK 465 ASN A 194 REMARK 465 SER A 195 REMARK 465 HIS A 196 REMARK 465 LYS A 197 REMARK 465 LYS A 198 REMARK 465 GLY A 199 REMARK 465 ALA A 200 REMARK 465 GLY B 47 REMARK 465 SER B 48 REMARK 465 SER B 49 REMARK 465 HIS B 50 REMARK 465 HIS B 51 REMARK 465 HIS B 52 REMARK 465 HIS B 53 REMARK 465 HIS B 54 REMARK 465 HIS B 55 REMARK 465 SER B 56 REMARK 465 SER B 57 REMARK 465 GLY B 58 REMARK 465 LEU B 59 REMARK 465 PRO B 61 REMARK 465 ARG B 62 REMARK 465 GLY B 63 REMARK 465 SER B 64 REMARK 465 HIS B 65 REMARK 465 MET B 66 REMARK 465 SER B 67 REMARK 465 ASN B 68 REMARK 465 PRO B 69 REMARK 465 LYS B 70 REMARK 465 LYS B 71 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 LYS B 193 REMARK 465 ASN B 194 REMARK 465 SER B 195 REMARK 465 HIS B 196 REMARK 465 LYS B 197 REMARK 465 LYS B 198 REMARK 465 GLY B 199 REMARK 465 ALA B 200 REMARK 465 GLY C 47 REMARK 465 SER C 48 REMARK 465 SER C 49 REMARK 465 HIS C 50 REMARK 465 HIS C 51 REMARK 465 HIS C 52 REMARK 465 HIS C 53 REMARK 465 HIS C 54 REMARK 465 HIS C 55 REMARK 465 SER C 56 REMARK 465 SER C 57 REMARK 465 GLY C 58 REMARK 465 LEU C 59 REMARK 465 VAL C 60 REMARK 465 PRO C 61 REMARK 465 ARG C 62 REMARK 465 GLY C 63 REMARK 465 SER C 64 REMARK 465 HIS C 65 REMARK 465 MET C 66 REMARK 465 SER C 67 REMARK 465 ASN C 68 REMARK 465 PRO C 69 REMARK 465 LYS C 70 REMARK 465 LYS C 71 REMARK 465 PRO C 72 REMARK 465 GLY C 73 REMARK 465 ARG C 74 REMARK 465 VAL C 75 REMARK 465 GLU C 183 REMARK 465 GLU C 184 REMARK 465 GLN C 185 REMARK 465 GLU C 186 REMARK 465 LEU C 187 REMARK 465 VAL C 188 REMARK 465 VAL C 189 REMARK 465 THR C 190 REMARK 465 ILE C 191 REMARK 465 PRO C 192 REMARK 465 LYS C 193 REMARK 465 ASN C 194 REMARK 465 SER C 195 REMARK 465 HIS C 196 REMARK 465 LYS C 197 REMARK 465 LYS C 198 REMARK 465 GLY C 199 REMARK 465 ALA C 200 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 183 CG CD OE1 OE2 REMARK 470 GLU B 184 CG CD OE1 OE2 REMARK 470 GLN B 185 CG CD OE1 NE2 REMARK 470 GLN C 182 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH C 2026 O HOH C 2027 2.14 REMARK 500 O HOH B 2034 O HOH B 2038 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO B 102 153.69 -47.99 REMARK 500 LEU C 110 74.28 -119.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2028 DISTANCE = 6.95 ANGSTROMS REMARK 525 HOH A2055 DISTANCE = 6.66 ANGSTROMS REMARK 525 HOH B2001 DISTANCE = 6.15 ANGSTROMS REMARK 525 HOH C2050 DISTANCE = 7.17 ANGSTROMS REMARK 525 HOH C2051 DISTANCE = 6.73 ANGSTROMS REMARK 525 HOH C2052 DISTANCE = 6.87 ANGSTROMS REMARK 525 HOH C2053 DISTANCE = 6.86 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1187 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P9I A 1185 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P9I B 1188 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P9I C 1183 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 1184 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1186 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1187 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4A9K RELATED DB: PDB REMARK 900 BROMODOMAIN OF HUMAN CREBBP WITH N-(4-HYDROXYPHENYL) ACETAMIDE REMARK 900 RELATED ID: 4A9E RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1 ,2,3,4- REMARK 900 TETRAHYDROQUINAZOLIN-2-ONE REMARK 900 RELATED ID: 4A9M RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N- CYCLOPENTYL-5-(3,5- REMARK 900 DIMETHYL-1,2-OXAZOL-4-YL)-2- METHYLBENZENE-1-SULFONAMIDE REMARK 900 RELATED ID: 4A9H RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-(2- METHYL-1,2,3,4- REMARK 900 TETRAHYDROQUINOLIN-1-YL)ETHAN-1-ONE REMARK 900 RELATED ID: 4A9F RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1- METHYLPYRROLIDIN-2-ONE REMARK 900 RELATED ID: 4A9L RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3- DIMETHYL-6- REMARK 900 (MORPHOLINE-4-SULFONYL)-1,2,3,4- TETRAHYDROQUINAZOLIN-2-ONE REMARK 900 RELATED ID: 4A9J RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(4- HYDROXYPHENYL) REMARK 900 ACETAMIDE DBREF 4A9I A 67 200 UNP P25440 BRD2_HUMAN 67 200 DBREF 4A9I B 67 200 UNP P25440 BRD2_HUMAN 67 200 DBREF 4A9I C 67 200 UNP P25440 BRD2_HUMAN 67 200 SEQADV 4A9I GLY A 47 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER A 48 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER A 49 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS A 50 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS A 51 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS A 52 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS A 53 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS A 54 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS A 55 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER A 56 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER A 57 UNP P25440 EXPRESSION TAG SEQADV 4A9I GLY A 58 UNP P25440 EXPRESSION TAG SEQADV 4A9I LEU A 59 UNP P25440 EXPRESSION TAG SEQADV 4A9I VAL A 60 UNP P25440 EXPRESSION TAG SEQADV 4A9I PRO A 61 UNP P25440 EXPRESSION TAG SEQADV 4A9I ARG A 62 UNP P25440 EXPRESSION TAG SEQADV 4A9I GLY A 63 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER A 64 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS A 65 UNP P25440 EXPRESSION TAG SEQADV 4A9I MET A 66 UNP P25440 EXPRESSION TAG SEQADV 4A9I GLY B 47 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER B 48 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER B 49 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS B 50 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS B 51 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS B 52 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS B 53 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS B 54 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS B 55 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER B 56 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER B 57 UNP P25440 EXPRESSION TAG SEQADV 4A9I GLY B 58 UNP P25440 EXPRESSION TAG SEQADV 4A9I LEU B 59 UNP P25440 EXPRESSION TAG SEQADV 4A9I VAL B 60 UNP P25440 EXPRESSION TAG SEQADV 4A9I PRO B 61 UNP P25440 EXPRESSION TAG SEQADV 4A9I ARG B 62 UNP P25440 EXPRESSION TAG SEQADV 4A9I GLY B 63 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER B 64 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS B 65 UNP P25440 EXPRESSION TAG SEQADV 4A9I MET B 66 UNP P25440 EXPRESSION TAG SEQADV 4A9I GLY C 47 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER C 48 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER C 49 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS C 50 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS C 51 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS C 52 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS C 53 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS C 54 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS C 55 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER C 56 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER C 57 UNP P25440 EXPRESSION TAG SEQADV 4A9I GLY C 58 UNP P25440 EXPRESSION TAG SEQADV 4A9I LEU C 59 UNP P25440 EXPRESSION TAG SEQADV 4A9I VAL C 60 UNP P25440 EXPRESSION TAG SEQADV 4A9I PRO C 61 UNP P25440 EXPRESSION TAG SEQADV 4A9I ARG C 62 UNP P25440 EXPRESSION TAG SEQADV 4A9I GLY C 63 UNP P25440 EXPRESSION TAG SEQADV 4A9I SER C 64 UNP P25440 EXPRESSION TAG SEQADV 4A9I HIS C 65 UNP P25440 EXPRESSION TAG SEQADV 4A9I MET C 66 UNP P25440 EXPRESSION TAG SEQRES 1 A 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 A 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 A 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 A 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 A 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 A 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 A 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 A 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 A 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 A 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 A 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 A 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA SEQRES 1 B 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 B 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 B 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 B 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 B 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 B 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 B 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 B 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 B 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 B 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 B 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 B 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA SEQRES 1 C 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 C 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 C 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 C 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 C 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 C 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 C 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 C 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 C 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 C 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 C 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 C 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA HET P9I A1185 18 HET SO4 A1186 5 HET SO4 A1187 5 HET EDO B1187 4 HET P9I B1188 18 HET P9I C1183 18 HET SO4 C1184 5 HETNAM P9I 1-[1-(PYRIDIN-2-YL)INDOLIZIN-3-YL]ETHAN-1-ONE HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 4 P9I 3(C15 H13 N2 O 1+) FORMUL 5 SO4 3(O4 S 2-) FORMUL 7 EDO C2 H6 O2 FORMUL 11 HOH *233(H2 O) HELIX 1 1 THR A 76 VAL A 85 1 10 HELIX 2 2 VAL A 85 LYS A 92 1 8 HELIX 3 3 ALA A 96 ARG A 100 5 5 HELIX 4 4 ASP A 104 GLY A 109 1 6 HELIX 5 5 ASP A 112 ILE A 117 1 6 HELIX 6 6 ASP A 122 ASN A 132 1 11 HELIX 7 7 ALA A 137 ASN A 156 1 20 HELIX 8 8 ASP A 160 ALA A 178 1 19 HELIX 9 9 THR B 76 VAL B 85 1 10 HELIX 10 10 VAL B 85 LYS B 92 1 8 HELIX 11 11 ALA B 96 ARG B 100 5 5 HELIX 12 12 ASP B 104 GLY B 109 1 6 HELIX 13 13 ASP B 112 ILE B 117 1 6 HELIX 14 14 ASP B 122 ASN B 132 1 11 HELIX 15 15 ALA B 137 ASN B 156 1 20 HELIX 16 16 ASP B 160 ALA B 178 1 19 HELIX 17 17 THR C 76 VAL C 85 1 10 HELIX 18 18 VAL C 85 LYS C 92 1 8 HELIX 19 19 ALA C 96 ARG C 100 5 5 HELIX 20 20 ASP C 112 ILE C 117 1 6 HELIX 21 21 ASP C 122 ASN C 132 1 11 HELIX 22 22 ALA C 137 ASN C 156 1 20 HELIX 23 23 ASP C 160 SER C 179 1 20 SITE 1 AC1 5 TRP A 97 ILE A 162 P9I A1185 GLN B 94 SITE 2 AC1 5 HOH B2088 SITE 1 AC2 7 TRP A 97 VAL A 103 LEU A 108 ASN A 156 SITE 2 AC2 7 ILE A 162 HOH A2037 EDO B1187 SITE 1 AC3 5 TRP B 97 PRO B 98 LEU B 108 ASN B 156 SITE 2 AC3 5 HOH B2032 SITE 1 AC4 6 GLN A 80 TRP C 97 PRO C 98 ASN C 156 SITE 2 AC4 6 ILE C 162 HOH C2016 SITE 1 AC5 7 ARG B 100 ARG C 128 ASN C 132 TYR C 134 SITE 2 AC5 7 HOH C2027 HOH C2032 HOH C2049 SITE 1 AC6 3 ARG A 100 HOH A2012 HOH A2091 SITE 1 AC7 5 THR A 125 ARG A 128 ARG A 129 HOH A2053 SITE 2 AC7 5 HOH A2057 CRYST1 114.232 55.531 67.975 90.00 94.85 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008754 0.000000 0.000743 0.00000 SCALE2 0.000000 0.018008 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014764 0.00000